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Objective: To [1] compare the frequency and severity of ultrasound (US) features in people with normal
knees (controls), knee pain (KP), asymptomatic radiographic OA (ROA), and symptomatic OA (SROA), [2]
examine relationships between US features, pain and radiographic severity, [3] explore the relationship
between change in pain and US features over a 3-month period.
Method: Community participants were recruited into a multiple group caseecontrol study. All under-
went assessment for pain, knee radiographs and US examination for effusion, synovial hypertrophy,
popliteal cysts and power Doppler (PD) signal within the synovium. A 3-month follow-up was under-
taken in over half of control and SROA participants.
Results: 243 participants were recruited (90 controls; 59 KP; 32 ROA; 62 SROA). Effusion and synovial
hypertrophy were more common in ROA and SROA participants. Severity of effusion and synovial hy-
pertrophy were greater in SROA compared to ROA (P < 0.05). Severity of US effusion and synovial hy-
pertrophy were correlated with radiographic severity (r ¼ 0.6 and r ¼ 0.7, P < 0.01) but the relationship
between pain severity and US features was weak (r ¼ 0.3, P < 0.01). In SROA participants, pain severity
did not change in tandem with a change in synovial hypertrophy over time.
Conclusion: US abnormalities are common in OA. Effusion and synovial hypertrophy were moderately
correlated with radiographic severity but the relationship with pain is less strong. The degree to which
these features reﬂect “active inﬂammation” is questionable and they may be better considered as part of
the total organ pathology in OA. Further studies are warranted to conﬁrm these ﬁndings.
© 2014 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.
0/).Introduction
Pain is the major stimulus for people with knee osteoarthritis
(OA) to seek medical attention but the causes of pain are complex
and radiographs which are the standard for clinical imaging in OA
are often discordant with symptoms1,2. In recent years there has
been increasing interest in the role of the synovium in painful OA.
Although nowhere as ﬂorid or extensive as the inﬂammation
observed in rheumatoid arthritis, clinical effusions and capsular: M. Hall, School of Health
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r Ltd and Osteoarthritis Research Sthickening can be clinically evident in some joints with knee OA,
and are more frequently observed using sensitive measures such as
ultrasound (US) and MRI3e10. Synovial changes in OA are regarded
by many as a secondary response to the degradation of cartilage11
though there are others who advocate them as a primary driver
for OA which may be partly responsible for pain and disease
progression12e16.
US allows the direct and indirect evaluation of synovial abnor-
malities, namely the presence of grey-scale features (effusion, sy-
novial hypertrophy and bursitis) which are widely considered to be
features of inﬂammation in OA. In addition the presence of
increased power Doppler signal (PDS) within the synovium is
purported to represent more active inﬂammation17. Synovial ab-
normalities are more common in those with painful knee OA
compared to those with asymptomatic OA or normal knees but the
association between individual US features and pain is not con-
clusive6,9,10,18e20. Indeed, no single US feature has been consistentlyociety International. This is an open access article under the CC BY-NC-ND license
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presence of effusion and synovial hypertrophy may be a marker for
structural damage as opposed to inﬂammation4,5. Additionally,
most US studies have been conducted in secondary care settings
and the same may not apply to people with knee OA in the com-
munity where the vast majority of patients are managed.
The primary aim of this study was to compare the frequency and
severity of synovial abnormalities in people with normal knees, KP,
radiographic OA and symptomatic OA from the community. Sec-
ondary aims were to examine the relationships between US fea-
tures, pain and radiographic severity and to observe whether
temporal change in pain severity over a 3-month period correlated
with a change in US ﬁndings.
Methods
A caseecontrol designwas used to compare four groups: people
with normal knees (controls e without pain and without radio-
graphic OA), KP without radiographic OA, asymptomatic radio-
graphic OA (ROA) and symptomatic ROA (SROA). KP was classiﬁed
according to the worst item score on any of the ﬁve Western
Ontario and McMaster Osteoarthritis Index (WOMAC) pain items.
Those reporting at least moderate pain were classiﬁed as pain
positive and those reporting none or mild pain were classiﬁed as
pain negative. Radiographic OAwas deﬁned as Kellgren& Lawrence
(K/L) grade 221.
Participants were recruited from previous community studies of
KP or knee OA (as either cases or controls) where they had con-
sented to being approached for future research. The primary source
of study participants was a cohort study of incident KP in the
community22. Additional participants were recruited from a rand-
omised controlled trial of non-prescription analgesics for people
with chronic KP23 and a population based caseecontrol study
(Genetics of OA and Lifestyle (GOAL)) study24. Participants were
purposefully recruited with the aim of attaining ﬁfty participants in
each of the four comparison groups. Sample size was based on a
best estimate from the limited published data for prevalence of
knee effusion for each group5,9,10. Assuming a prevalence of 60% in
the SROA group, 30% in the KP and ROA group and 5% in the control
group, 50 participants were required in each group (200 in total) to
detect the minimum difference between groups with 90% power
and <5% type 1 errors. Control and SROA participants were invited
to attend a follow-up US and pain assessment at 3 months.
Participants were excluded if they had a clinical history of in-
ﬂammatory arthritis, clinical hip OA, knee joint replacement, knee
joint injury or surgery in the previous 3months, steroid injection to
either knee in the previous 3months, a diagnosis of Fibromyalgia or
chronic widespread pain or severely impaired mobility (Stein-
brocker Grade IV). Participants were asked to refrain from taking
any non-steroidal anti-inﬂammatory drugs (NSAID) for 48 h prior
to the assessment to allow an adequate wash-out period; para-
cetamol could be taken for rescue pain-relief up to 12 h before.
Study approval was granted by the Derbyshire Research Ethics
Committee and all participants gave written informed consent. All
participants underwent a clinical assessment, US and radiographic
evaluation between April 2010 and March 2012.
Assessments
A range of data was collected including age, gender, body mass
index (BMI), duration of early morning stiffness (EMS) (minutes)
and the presence of a moderate clinical knee effusion. The
WOMAC was also used to evaluate knee stiffness and function25.
Pain was assessed using three measures, a visual analogue scale
(VAS) from 0 to 100mm for current KP severity, the pain subscale ofthe WOMAC questionnaire25 and the Measure of Intermittent and
Constant Osteoarthritis Pain questionnaire (ICOAP)26.
Standardised, weight-bearing, semi-ﬂexed tibio-femoral and
skyline 30 patello-femoral radiographs were scored by a single
reader (SD) who was blinded to US features and pain. Radiographs
were scored using the Nottingham logically derived Line Drawing
Atlas (LDA)27,28. This scoring systemusesmathematically calculated
intervals for grading joint space width (JSW) and size of osteophyte
for all three compartments of the knee, to produce an ordinal
summated score. Intra-observer reproducibility for scoring using
the LDA has been established as good (kappa ¼ 0.82 (95%, CI
0.78e.089) for JSW and 0.68 (95% CI, 0.63e0.71) for size of osteo-
phyte)27. An overall K/L grade (0e4) was also given to each knee.
US assessment
US was performed by a single assessor (MH) on the same day as
clinical assessments using a Toshiba Aplio SSA-770A machine with
amulti-frequency (7e12MHz) linear array transducer. The assessor
was blind to the radiographic scores but not the clinical ﬁndings.
A standardised protocol reﬂecting current deﬁnitions and
guidelines was followed5,29. Knees were scanned in longitudinal
and transverse planes with the joint supported in 30 ﬂexion for
ventral and lateral scans and in extension for dorsal scans. The
supra-patellar pouch was scanned widely (including the lateral and
medial recesses). The following features and measurements were
recorded:
(1) Effusion: maximal depth was measured in mm and dicho-
tomised as absent if <4 mm and present if 4 mm5.
(2) Synovial hypertrophy: maximal depth was measured in mm
and dichotomised as absent if <4mm and present if4mm5.
(3) Baker's cyst: the diameter was measured in the transverse
plane and dichotomised as absent if <4 mm or present if
4 mm10.
(4) Bursitis: bursae at the infra-patellar tendon and the insertion
of the pes-anserinus site were measured and dichotomised
as absent if <4mm or present if4mm infra-patellar bursae,
and absent if <2 mm or present if 2 mm for the pes-
anserine bursa10.
(5) PDS: areas of hypertrophic synovium were scanned. A pulse
repetition frequency of 1000e1300 Hz with a medium wall
ﬁlter was used and the gain was adjusted so the background
signal was removed. Increased signal was observed in both
longitudinal and transverse planes and was scored using a
semi-quantitative system grade 0e3, (0 ¼ absent, 1 ¼ mild,
2 ¼ moderate, 3 ¼ marked or severe)7.
Intra-observer reliability for US measures was tested by per-
forming a second scan within 1 week on 28 knees by the same
assessor (MH). Intra-class correlation coefﬁcients (ICC) were
calculated for continuous measures of effusion 0.93 (95% CI,
0.75e0.98), synovial hypertrophy 0.89 (95% CI, 0.64e0.97) and
popliteal cysts 0.79 (95% CI, 0.61e0.90). Intra-observer reliability
for PDS was evaluated using a weighted kappa and was statistically
perfect, kappa¼ 1.0 (P < 0.001), but will have been inﬂuence by the
low occurrence of PDS.
Statistical analysis
Our primary analysis was to compare the differences between
groups. Analyses were carried out on data for the index knee (the
most symptomatic, or randomly chosen knee) using IBM SPSS
Statistics 19. All analyses were tested at the signiﬁcance level
P < 0.05. For nominal or frequency data the Chi-square test was
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quencies were less than ﬁve. Post-hoc comparisons were made
using the z-test with adjusted P values (the Bonferroni method was
used whenmaking multiple paired comparisons to control for Type
I error rates). The distributions of continuous variables were tested
using the KolmogoroveSmirnov test. Differences between groups
were then compared using the one-way ANOVA and post-hoc
Bonferroni tests for normally distributed data and the Krus-
kaleWallis test and post-hoc ManneWhitney tests with a Bonfer-
roni correction for non-normally distributed data.
Secondary analysis examined the relationships between
continuous USmeasures, pain VAS scores and radiographic severity
(Nottingham LDA scores) using Pearson's correlation coefﬁcients or
Spearman's rho. Change in pain VAS scores and US measures at 3-
month follow-up was examined using a paired t-test or Wilcoxon
Signed Ranks Test, and correlation analysis was used to examine
relationships between change in pain severity and change in US
measures.Results
Characteristics of study groups
Baseline assessments were performed on 243 participants, 65%
were women, mean age was 70 years and BMI was 28.1 kg/m2. The
four study groups were made up of 90 controls, 59 KP, 32 ROA, and
62 SROA participants. Recruited participants were representative of
their original studies in terms of age though more females than
males were recruited. Final recruitment to each group was unbal-
anced, with the ROA group under represented and SROA group over
represented in the ﬁnal analysis.
Baseline characteristics for each group are presented in Table I.
The gender distribution between each groupwas similar but the KP
group was younger (P < 0.05) and the control group had a lower
BMI (P < 0.05) compared to other groups. Pain variables did not
differ between the KP and SROA groups. Radiographic severity (LDA
scores) were higher in the SROA group compared to ROA group
(P ¼ 0.05). Clinical effusions were rare among controls (2.2%) and
KP participants (3.4%) but were more common in ROA (15.6%)
(P < 0.05) and again in SROA (50%), (P ¼ 0.05). Morning stiffness
30 min duration was exclusively reported by those with pain.Table I
Clinical characteristics of each group
Characteristics Controls (N ¼ 90) KP (N
Age (years) mean (SD) 71 (7.9) 63.8 (8
BMI (kg/m2) mean (SD) 26.5 (4.4)** 28.5 (4
Women n (%) 63 (70%) 33 (5
Nottingham LDA scores
Global score (0e60) mean (SD) 1.1 (1.5) 0.5 (1
Pain characteristics
Pain VAS (mm) mean (SD) 6.6 (11.0) 48.9 (2
WOMAC pain (0e20) mean (SD) 1.0 (1.51) 8.0 (3
ICOAP subscales
Constant (0e20) mean (SD) 0.5 (1.2) 5.9 (4
Intermittent (0e24) mean (SD) 1.6 (2.5) 10.2 (4
Clinical
Clinical effusion n (%) 2 (2.2%) 2 (3
EMS  30 min n (%) 0 (0%) 20 (3
WOMAC stiffness (0e8) mean (SD) 0.8 (1.1) 3.4 (1
WOMAC function (0e68) mean (SD) 4.2 (6.5) 25.8 (1
P value represents signiﬁcant difference between the four groups using Х 2 tests for freq
*group differs signiﬁcantly from control P < 0.05 after applying post-hoc Bonferroni test
**group differs signiﬁcantly from all groups P < 0.05 after applying post-hoc Bonferroni
ROA, radiographic OA; SROA, symptomatic OA; EMS  30 min, a dichotomous variable wUS ﬁndings at baseline
Table II summarises the US ﬁndings for each group. We found no
difference in the frequency or severity of US features between
control and KP participants. Effusions, synovial hypertrophy and
popliteal cysts weremore frequently observed in the ROA and SROA
groups compared to KP and control groups (P < 0.05) (Fig. 1). Sy-
novial hypertrophywasmore common again in the SROA compared
to ROA group (P < 0.05). The frequency of popliteal cysts increased
in ROA (21.9%, P < 0.05) and SROA (39%, P < 0.05) groups compared
to controls but were not different to each other. PD signal was more
frequently observed in of SROA participants (16%) than control (2%,
P < 0.05) and KP (3%, P < 0.05) groups. Grade of PD signal was not
subject to analysis due to the low frequency observed. Infra-patellar
bursae and pes-anserine bursae were rare and did not differ be-
tween groups.
Continuous measures of effusions and synovial hypertrophy
were greater in ROA (mean depth (SD) ¼ 6.0 mm (2.8) and 3.9 mm
(3.9) respectively) compared to controls and KP groups (P < 0.05),
and were greater again in the SROA group (mean depth
(SD)¼ 8.1 mm (4.0) and 6.7 mm (3.3), P < 0.05 respectively) (Fig. 2).Relationships between US features, pain and radiographic severity
We found moderate correlations between radiographic scores
derived from the Nottingham LDA and direct US measures of
effusion and synovial hypertrophy (r ¼ 0.6 and r ¼ 0.7 respectively,
P  0.01) (Table III). Correlations between pain VAS scores and US
measures were weak but signiﬁcant for effusion and synovial hy-
pertrophy (r ¼ 0.3, P < 0.01) (Table III). The strength of the corre-
lation was similar for pain assessed using the VAS, WOMAC and
ICOAP scores.Change in pain and US measures at 3 months
At 3 months, follow-up assessments for pain and US measures
were carried out in 45 (72.5%) of SROA participants and 57 (63%) of
controls (Table IV). Pain VAS scores and USmeasures did not change
within the control group. In the SROA group, there was a statisti-
cally signiﬁcant reduction in mean depth of synovial hypertrophy
(mean difference¼1.4mm SD (3.0), P¼ 0.003) after 3months but¼ 59) ROA (N ¼ 32) SROA (N ¼ 62) P
.8)** 73.1 (7.9) 73.9 (7.8) <0.001
.0) 29.6 (5.3) 29.2 (4.1) ¼0.001
5.9%) 19 (59.3%) 42 (67.7%) ¼0.29
.1) 11.9 (7.1)* 17.5 (8.0)** <0.001
2.0)* 7.2 (14.4) 48.2 (24.6)* <0.001
.34)* 0.9 (1.34) 8.1 (3.23)* <0.001
.8)* 0.2 (.59) 6.9 (5.2)** <0.001
.1)* 2.0 (3.1) 10.6 (5.5)** <0.001
.4%) 5 (15.6%)* 31 (50%)** <0.001
7.7%)* 0 (0%) 15 (27.3%)* <0.001
.6)* 0.9 (0.9) 4.0 (1.8)* <0.001
2.3)* 5.5 (6.6) 29.6 (11.8)* <0.001
uency data and one-way ANOVA for continuous data.
.
test.
as created for EMS lasting longer than 30 min.
Table II
Frequency and severity of Ultrasound (US) features
US features Controls (n ¼ 90) KP (n ¼ 59) ROA (n ¼ 32) SROA (n ¼ 62) P
Effusion n (%) 26 (28.9) 19 (32.2) 26 (81.3)* 57 (91.9)* <0.001
Synovial hypertrophy n (%) 7 (7.8) 7 (11.9) 13 (40.6)* 51 (82.3)** <0.001
Popliteal cysts n (%) 11 (12.4) 5 (8.6) 7 (21.9)* 23 (39.2)* <0.001
Infra-pat bursitis n (%) 3 (3.3) 4 (6.8) 0 (0) 5 (8.1) 0.28
Pes-anserine bursitis n (%) 0 (0) 0 (0) 0 (0) 4 (6.5) ns
PDS n (%) 2 (2.2) 2 (3.4) 2 (6.3) 10 (16.2)* ¼0.005
Grade 1 n (%) 2 (2.2) 1 (1.7) 2 (6.3) 5 (8.1)
Grade 2 n (%) 0 (0) 0 (0) 0 (0) 5 (8.1)
Grade 3 n (%) 0 (0) 1 (1.7) 0 (0) 0 (0)
Continuous US features
Effusion (mm) mean (SD) 2.6 (2.7) 3.4 (3.2) 6.0 (2.8)* 8.1 (4.0)** <0.001
Synovial hypertrophy (mm) mean (SD) 0.7 (1.5) 1.0 (1.9) 3.9 (3.9)* 6.7 (3.3)** <0.001
Popliteal cysts (mm) mean (SD) 1.0 (2.6) 0.8 (2.2) 1.8 (3.6) 3.5 (4.7)* ¼0.001
P value represents signiﬁcant difference between the four groups using Х 2 tests for frequency data and one-way ANOVA for continuous data.
*differs signiﬁcantly from control and KP group P < 0.05.
**differs signiﬁcantly from all groups P < 0.05.
ROA, radiographic OA; SROA, symptomatic OA.
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pain measures. We found no correlation between change in pain
and change in US measures for either group (data not shown)
though a change in US effusion was strongly correlated with a
change in synovial hypertrophy that was statistically signiﬁcant for
both control (r ¼ 0.4, P < 0.05) and SROA groups (r ¼ 0.6, P < 0.01).
Discussion
This ﬁrst community-based US study has conﬁrmed that US
features are more common in those with radiographic OA
compared to those without and that severity of effusion and sy-
novial hypertrophy are greater in those with painful OA. We found
that direct measures of US features were moderately correlated
with radiographic severity but had a weaker relationship with pain
severity. Over a 3-month period, SROA participants showed a
reduction in mean synovial hypertrophy but there was no parallel
reduction in KP suggesting that, in the community at least, US
features accompany structural changes of knee OA but do not
readily explain the severity of pain.
Previous studies have shown grey-scale US features to be
common in SROA though prevalence rates vary between 33 and
86% for effusion8,30 17e93% for synovial hypertrophy5,8 and 6e43%
for popliteal cysts7,8. Our frequency data are higher than some
studies which may be attributable to variations in scanning pro-
tocols. We included the medial and lateral recesses of the supra-
patellar pouch and joint lines when scanning and our ﬁndings are
more comparable with those who scanned the joint widely8. PD
signal is frequently cited as a surrogate for active synovitis but is notFig. 1. Bar chart showing frequency (%) of US features within each comparison group.commonly reported in US studies of knee OA6,31,32. Our study is one
of only a few that has reported using PDS and though we found it
more frequently in SROA participants (16%, P < 0.05) compared to
all other groups the severity was graded as only mild-moderate.
Few studies have directly investigated the relationship between
radiographic severity and US features in knee OA. D'agostino et al.
reported the presence of grey-scale US features was associatedwith
higher radiological scores (K/L grade 3e4)5, and MRI studies have
also reported a signiﬁcant relationship between synovial hyper-
trophy and radiographic severity33. Using the Nottingham LDA we
were able to correlate direct measures of US features with ordinalFig. 2. US measures of (A) effusion and (B) synovial hypertrophy for each group.
Table III
Correlations between continuous US measures, pain severity and radiographic
severity
Effusion
(mm)
Synovial
hypertrophy
(mm)
Popliteal
cyst (mm)
Pain VAS (mm) 0.3** 0.3** 0.1
WOMAC pain subscale 0.3** 0.3** 0.1
ICOAP intermittent subscale 0.3** 0.3** 0.1
ICOAP constant subscale 0.3** 0.3** 0.1
Radiographic severity e
Nottingham LDA score (0e60)
0.6** 0.7** 0.3**
**Correlation is signiﬁcant at the 0.01 level.
mm, millimeters.
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radiographic severity and USmeasures of synovial hypertrophy and
effusion, which to us suggests that direct and indirect changes of
the synovium are a reﬂection of the overall structural damage and
reparative attempts of the osteoarthritic joint.
Previous conclusions on the relationship between US features
and pain is knee OA are inconsistent. De Miguel et al. reported US
effusion to increase the risk of KP by 6.5 times and Baker's cysts by
5.5 times but found no association between US features and pain
severity10. Others have reported positive associations between US
effusion with higher pain VAS scores on motion and at rest9,34.
However, two recent cross-sectional studies reported no associa-
tion between US features and either the presence of KP or pain
severity6,20. We examined correlations between different pain
measures (pain VAS, WOMAC, ICOAP intermittent and constant
subscales) and direct measures of grey-scale features and found
that both effusions and synovial hypertrophy were both correlated
with pain severity but only modestly so. There was also no differ-
ence between the strength of the relationship for intermittent KP
and constant KP, which may be thought of as more mechanical and
inﬂammatory type pain, respectively. Little has been reported on
the temporal changes of US features relative to change in KP. MRI
studies have shown that while an increase in synovitis correlates
modestly with increased pain severity or more frequent pain, a
reciprocal decrease is not observed when pain decreases35,36. We
found that in SROA participants mean measures of synovial hy-
pertrophy decreased over a 3-month period but this was not
accompanied by a parallel reduction in pain severity.
This suggests that perhaps synovial hypertrophy as observed on
grey-scale US is not as “inﬂammatory” as we would like to believe.
Previous studies have shown that grey-scale US cannot differen-
tiate between synovial hypertrophy and synovitis, tissue debris and
ﬁbrosis are known to mimic some US features of synovial prolif-
eration but these features do not exhibit PD signal37e39. We found
hypertrophy to be common but PD signal much less so. This raises
the question that if effusion and synovial hypertrophy detected byTable IV
Pain and US measures in control and SROA participants at baseline and 3 months
Controls N ¼ 57
Baseline 3 months
Pain VAS (mm) 3.1 (5.6) 5.8 (13.6)
Effusion (mm) 2.3 (2.4) 2.2 (2.4)
Synovial hypertrophy (mm) 0.6 (1.5) 0.7 (1.9)
Popliteal cysts (mm) Median (range) 0 (0e11.6) 0 (0e12.4)
Data represent mean (SD) unless stated.
P value represents signiﬁcant difference between the baseline and 3 months using pair
distributed data. *difference is signiﬁcant at <0.05.
SROA, symptomatic OA.US are not “inﬂammatory” in nature then what do they represent?
The reduction in lymphatic vessels that occurs in knee OA syno-
vium could cause increased synovial thickening and effusion
through altered dynamics of ﬂuid drainage rather than from
“inﬂammation”40, and it has been suggested that altered joint
biomechanics may permanently modify the baseline volume of
synovial ﬂuid41. In knee OA, the precipitating event is almost always
mechanical in nature resulting either from acute injury, repetitive
micro-trauma, increased focal stresses from abnormal anatomy or a
combination thereof11. Capsular tissues are dynamic in terms of
synthesis and orientation and respond to the biomechanical forces
acting on them. Importantly, synovial thickening is localised rather
than diffuse in OA and this may be reﬂective of damage in the
adjacent areas of cartilage, bone or entheses but may also represent
a cellular response to biomechanical stresses within the joint
capsule. Different patterns of synovial thickening on US and MRI
have been identiﬁed but whether they are associated with joint
biomechanics has not yet been investigated8,42,43. It seems likely
from our data that effusion and synovial hypertrophymainly reﬂect
the overall changes that occur in knee OA.
There are some caveats to this study. Firstly, recruitment to the
study was not random; participants were purposefully recruited to
each study group with the aim of comparing four groups with a
balanced number of 50 participants. Participants were drawn from
previous community studies of KP for whom a variable amount of
time (between 3 and 10 years) had passed between participation in
the original and current study22e24. As such, previous radiographic
and pain status may have changed for some potential participants
i.e., there would be an incidence of new radiographic OA and new
KP, as well as KP having resolved in others. The prevalence of
asymptomatic ROA lies between 27 and 44% of the general popu-
lation44 but identifying those participants is inherently difﬁcult as
they are asymptomatic and require radiographs to conﬁrm their
status. Consequently, recruitment to each group was unbalanced,
with the ROA group under represented and SROA group over rep-
resented in the ﬁnal analysis. Secondly, the study design was pri-
marily intended for the comparison of the four study groups.
Secondary analyses examining the relationships between pain,
structural change and US features were derived from the four
different groups and the correlations may not be representative of
the general population. Thirdly, the population for this study was
drawn from the community and differences in population de-
mographics limits direct comparisons with hospital-based US
studies where SROA participants are often younger, with less severe
radiographic changes but higher levels of reported pain5. Com-
parisons may also be limited by variations in deﬁnitions of US pa-
thology and scanning protocols which vary between studies.
Finally, issues around deﬁning KP and knee OA are well doc-
umented45e48. We chose our deﬁning criteria as it enabled all
participants to be allocated to a group. As a consequence the
comparison groups are not completely distinct, that is someP SROA N ¼ 45 P
Baseline 3 months
0.33 52.5 (23.0) 54.0 (25.5) 0.65
0.80 8.6 (4.6) 8.6 (4.9) 0.96
0.67 7.1 (4.0) 5.7 (4.3) 0.003*
0.53 0 (0e14.3) 1.15 (0e13.4) 0.45
ed t test for normally distributed and Wilcoxon signed rank test for non-normally
M. Hall et al. / Osteoarthritis and Cartilage 22 (2014) 1627e16331632control/ROA participants had mild symptoms and some control/KP
participants had minor structural change (K/L grade1).
In conclusion, this study highlights the correlation between
grey-scale US features and radiographic severity. However, it
questions the general assumption that synovial abnormalities are
“inﬂammatory” in nature and is responsible for driving pain in OA,
and suggests instead that they are a part of the overall structural
pathology reﬂecting the biomechanical adaptations of the OA joint.
PD signal which is widely asserted to represent a more “active
inﬂammation” was more common in painful OA compared to
controls but did not differ signiﬁcantly from asymptomatic OA but
this may not be the case for hospital referred patients. US features,
particularly synovial hypertrophy, may well have a role to play in
the development of painful OA but given the multi-factorial nature
of pain this is unlikely to be straight forward. Further longitudinal
studies are required to demonstrate whether US features are
important in the development and progression of structural change
and symptoms.
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